High expression of CD 44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine-Reference-Cited by-同舟云学术

High expression of CD 44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine

Published:2018-08-16 Issue:9 Volume:109 Page:2801-2810
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Wada Fumitaka¹²,Koga Hironori¹²^ORCID,Akiba Jun³,Niizeki Takashi¹,Iwamoto Hideki¹²,Ikezono Yu¹²,Nakamura Toru¹²,Abe Mitsuhiko¹²,Masuda Atsutaka¹²,Sakaue Takahiko¹²,Tanaka Toshimitsu¹²,Kakuma Tatsuyuki⁴,Yano Hirohisa³,Torimura Takuji¹²

Affiliation:

1. Division of Gastroenterology Department of Medicine Kurume University School of Medicine Kurume Japan

2. Liver Cancer Research Division Research Center for Innovative Cancer Therapy Kurume University Kurume Japan

3. Department of Pathology Kurume University School of Medicine Kurume Japan

4. Biostatistics Center Kurume University Kurume Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13728

Reference29 articles.

1. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012

2. Hepatocellular carcinoma

3. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study

4. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

5. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma;Pang RW;Curr Cancer Drug Targets,2012

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas;International Journal of Molecular Sciences;2024-08-24

2. Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation;Anti-Cancer Drugs;2024-07-01

3. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies;Life Sciences;2024-06

4. NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer;International Journal of Molecular Sciences;2024-06-01

5. Role of oxidative stress‐induced ferroptosis in cancer therapy;Journal of Cellular and Molecular Medicine;2024-05